Qiagen and Evotec to Collaborate on RNAi Analysis | GenomeWeb

NEW YORK, Sept. 16 (GenomeWeb News) - Qiagen and Evotec announced an agreement today to collaborate on ultra-high-throughput RNAi analysis. 

The companies said the collaboration will produce a series of scientific notes to describe applications that combine Evotec Technologies' Opera confocal fluorescence microplate reader automation and Qiagen's line of chemistry products for RNAi analysis.

 

Financial details of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.